Skip to main content
. 2022 Feb 7;40(12):1755–1760. doi: 10.1016/j.vaccine.2022.02.013

Table 2.

Multivariable weighted Cox hazard models of the association between 2020/21 influenza vaccination and SARS-CoV-2 first positive test (N = 2561).

Variable Level Model 1
Model 21
npHR (95% CI) p-value npHR (95% CI) p-value
Influenza vaccine No Ref Ref
Yes 0.37 (0.22–0.62) <0.001 0.17 (0.09–0.34) <0.001
Sex Male Ref Ref
Female 0.79 (0.55–1.16) 0.23 0.76 (0.52–1.11) 0.15
Age, years 1-year increase 1.00 (0.99–1.01) 0.91 0.99 (0.98–1.00) 0.17
Nationality Italian Ref Ref
Immigrant 1.38 (0.69–2.75) 0.37 1.39 (0.70–2.74) 0.34
SARS-CoV-2 testing frequency 1-unit increase 0.98 (0.93–1.04) 0.48 1.09 (1.02–1.16) 0.013

CI = confidence interval; npHR = non-proportional hazard ratio.

1

Adjusted for the week of the last SARS-CoV-2 RT-PCR testing.